dobutamine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, M; Nakamura, T; Sobue, G | 1 |
| Hamada, K; Hirayama, M; Ito, H; Koike, Y; Nakamura, T; Sobue, G; Takamori, M; Takeuchi, S; Watanabe, H | 1 |
1 review(s) available for dobutamine and Parkinson Disease
| Article | Year |
|---|---|
[Cardiac reserve in Parkinson's disease and exercise therapy].
Topics: Adrenergic beta-1 Receptor Agonists; Cardiac Output; Cardiovascular System; Dobutamine; Exercise; Exercise Therapy; Fatigue; Heart; Humans; Parkinson Disease; Pyramidal Tracts; Radionuclide Imaging; Sympathetic Nervous System | 2013 |
1 other study(ies) available for dobutamine and Parkinson Disease
| Article | Year |
|---|---|
Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Blood Pressure; Case-Control Studies; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Heart Rate; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathectomy; Sympathomimetics | 2007 |